BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8394402)

  • 1. [Evidence of elevated soluble plasma thrombomodulin in atherosclerosis].
    Conri C; Seigneur M; Constans J; Mercier P; Baste JC; Dufourcq P; Boisseau MR
    J Mal Vasc; 1993; 18(2):112-8. PubMed ID: 8394402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of plasma thrombomodulin are increased in atheromatous arterial disease.
    Seigneur M; Dufourcq P; Conri C; Constans J; Mercié P; Pruvost A; Amiral J; Midy D; Baste JC; Boisseau MR
    Thromb Res; 1993 Sep; 71(6):423-31. PubMed ID: 8134903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
    Bellucci S; Ignatova E; Jaillet N; Boffa MC
    Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
    Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
    Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
    Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
    Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
    Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
    Aguilera A; Sánchez-Tomero JA; Bajo MA; Ruiz-Caravaca ML; Alvarez V; del Peso G; Herranz A; Cuesta MV; Castro MJ; Selgas R
    Adv Perit Dial; 2003; 19():240-5. PubMed ID: 14763071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
    Blann AD; Dobrotova M; Kubisz P; McCollum CN
    Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue plasminogen activator and inhibitor and the severity and extensiveness of vascular lesions in peripheral atherosclerosis of the legs].
    Rość D; Zekanowska E; Hryncewicz W; Cwiklińska-Jurkowska M; Jurkowski P; Kotschy M
    Pol Merkur Lekarski; 1996 Oct; 1(4):235-7. PubMed ID: 9156932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
    Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.